Business Context and Reporting Period
Company: Genmab A/S
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: February 2026
Date Filed: February 17, 2026
Context: This filing serves to incorporate by reference a Company Announcement dated February 17, 2026 (Exhibit 99.1) into the registrant's existing Form S-8 registration statements.
Key Financial Metrics
The provided filing text contains only cover page metadata and an exhibit index. It does not include the full text of the Company Announcement or any financial tables. Consequently, the following metrics are not available in this document:
- Revenue
- Profit and Margins
- Cash Flow
- Debt and Liquidity
Note: The filing text does not provide a clear value for any financial metric.
Material Changes
No material changes versus prior periods can be identified from the provided text, as the specific content of the February 17, 2026 announcement is not included in the input.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, risk factors, or details regarding contingencies and unusual items. These details would be contained within the referenced Exhibit 99.1, which is not present in the source text.
Investor Verification Checklist
- Verify the full content of the "Company Announcement Dated February 17, 2026" (Exhibit 99.1) to understand the specific event triggering this filing.
- Confirm if the announcement relates to clinical trial data, regulatory approvals, partnership agreements, or financial results.
- Review the referenced Form S-8 registration statements to understand the scope of securities affected by this incorporation by reference.